PMDA inspection

Eli Lilly and Company

PMDA inspection 5130508027045 · USA · Suitable

Key facts

Control number 5130508027045
Manufacturing site Eli Lilly and Company
Location Lilly Corporate Center, Indianapolis, Indiana 46285, USA
Country USA
Product type Pharmaceuticals
Application type New
Inspection method Remote
Inspection month May 1, 2024
Result Suitable
Result notified Jun 3, 2024
PMDA registration AG30400327

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)